Ann: Annual Report 2017, page-21

Why, what is there that has not been discussed a dozen times in the last few months?

3 products released (cashflow positive first qtr when the first royalty appears)
1.6m operating cashflow needed to break even.
That is a royalty of 400k a qtr. Seriously a walk in the park. Especially given that 1m is to come from 2nd phase of tech 2 in 2018. They will not only be cash positive but most probably be profitable next fiscal.

Product 4 to be released most likely qtr 1 2018
Product 5 in 2018
product 6 in 2019

phase 1 of 2nd tech finishing by end of year, new deal to be contracted after that. So expect product end of 2018

Bodyguard manufacture testing was underway.
distributors waiting results obviously as can't negotiate until done. Need to know if it can be mass produced, what it costs, do people actually want it.
new testing expected as who would take a product with one test. Early 2019 est

Surface care again who would sign up without further testing and trials. Early 2019 est

All known and all expected unless you are too bullish or living in fairyland.